Thailand Neurodegenerative Disease Market (2025-2031) | Industry, Companies, Competitive Landscape, Trends, Segmentation, Outlook, Value, Growth, Analysis, Size & Revenue, Share, Forecast

Name: Thailand Neurodegenerative Disease Market (2025-2031) | Industry & Companies
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) And Competitive Landscape

Product Code: ETC9690165	Publication Date: Sep 2024	Updated Date: Oct 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

Thailand Neurodegenerative Disease Market Outlook
Market Size of Thailand Neurodegenerative Disease Market, 2024
Forecast of Thailand Neurodegenerative Disease Market, 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Revenues & Volume for the Period 2021- 2031
Thailand Neurodegenerative Disease Market Trend Evolution
Thailand Neurodegenerative Disease Market Drivers and Challenges
Thailand Neurodegenerative Disease Price Trends
Thailand Neurodegenerative Disease Porter's Five Forces
Thailand Neurodegenerative Disease Industry Life Cycle
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Indication Type for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Parkinson's Disease for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Alzheimer's Disease for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Huntington Disease for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Other Indication Types for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By N-methyl-D-aspartate Receptor Antagonists for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Immunomodulatory Drugs for the Period 2021- 2031
Historical Data and Forecast of Thailand Neurodegenerative Disease Market Revenues & Volume By Other Drug Types for the Period 2021- 2031
Thailand Neurodegenerative Disease Import Export Trade Statistics
Market Opportunity Assessment By Indication Type
Market Opportunity Assessment By Drug Type
Thailand Neurodegenerative Disease Top Companies Market Share
Thailand Neurodegenerative Disease Competitive Benchmarking By Technical and Operational Parameters
Thailand Neurodegenerative Disease Company Profiles
Thailand Neurodegenerative Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Thailand Neurodegenerative Disease Market Overview

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Neurodegenerative Disease Market - Industry Life Cycle

3.4 Thailand Neurodegenerative Disease Market - Porter's Five Forces

3.5 Thailand Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F

3.6 Thailand Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4 Thailand Neurodegenerative Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurodegenerative diseases in Thailand

4.2.2 Growing awareness and focus on healthcare in the region

4.2.3 Advancements in medical research and technology for diagnosis and treatment

4.3 Market Restraints

4.3.1 High treatment costs and limited access to specialized care

4.3.2 Lack of skilled healthcare professionals and infrastructure

4.3.3 Regulatory challenges and approval processes for new treatments

5 Thailand Neurodegenerative Disease Market Trends

6 Thailand Neurodegenerative Disease Market, By Types

6.1 Thailand Neurodegenerative Disease Market, By Indication Type

6.1.1 Overview and Analysis

6.1.2 Thailand Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F

6.1.3 Thailand Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.1.4 Thailand Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.1.5 Thailand Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.6 Thailand Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F

6.1.7 Thailand Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F

6.2 Thailand Neurodegenerative Disease Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 Thailand Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F

6.2.3 Thailand Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.4 Thailand Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.5 Thailand Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F

6.2.6 Thailand Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F

7 Thailand Neurodegenerative Disease Market Import-Export Trade Statistics

7.1 Thailand Neurodegenerative Disease Market Export to Major Countries

7.2 Thailand Neurodegenerative Disease Market Imports from Major Countries

8 Thailand Neurodegenerative Disease Market Key Performance Indicators

8.1 Average time from symptom onset to diagnosis

8.2 Number of clinical trials for neurodegenerative diseases in Thailand

8.3 Patient satisfaction with treatment options and healthcare services

8.4 Adoption rate of new diagnostic tools and treatment modalities

8.5 Investment in research and development for neurodegenerative diseases in Thailand

9 Thailand Neurodegenerative Disease Market - Opportunity Assessment

9.1 Thailand Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F

9.2 Thailand Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10 Thailand Neurodegenerative Disease Market - Competitive Landscape

10.1 Thailand Neurodegenerative Disease Market Revenue Share, By Companies, 2024

10.2 Thailand Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Afghanistan Neurodegenerative Disease Market

Africa Neurodegenerative Disease Market

Albania Neurodegenerative Disease Market

Global Neurodegenerative Disease Market

Middle East Neurodegenerative Disease Market

North America Neurodegenerative Disease Market

United Arab Emirates (UAE) Neurodegenerative Disease Market

United Kingdom (UK) Neurodegenerative Disease Market

United States (US) Neurodegenerative Disease Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here